Journal of Orthopedics and Joint Surgery

Register      Login

VOLUME 6 , ISSUE 1 ( January-June, 2024 ) > List of Articles

ORIGINAL RESEARCH ARTICLE

Comparing the Effectiveness of Intra-articular Injection with Autologous Platelet-rich Plasma vs Hyaluronic Acid vs Platelet-derived Growth Factors in Early Osteoarthritis of Knee Joint

Vidya S Konana, Harish S Yallapura, Sriharsha Bettaswamy, Srinivas P Sivaram, Darshan G Thimmegowda

Keywords : Hyaluronic acid, Intra-articular injections, Knee, Osteoarthritis, Platelet-rich plasma-derived growth factor, Platelet-rich plasma

Citation Information : Konana VS, Yallapura HS, Bettaswamy S, Sivaram SP, Thimmegowda DG. Comparing the Effectiveness of Intra-articular Injection with Autologous Platelet-rich Plasma vs Hyaluronic Acid vs Platelet-derived Growth Factors in Early Osteoarthritis of Knee Joint. 2024; 6 (1):27-34.

DOI: 10.5005/jojs-10079-1134

License: CC BY-NC 4.0

Published Online: 12-01-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Aims: To compare the effectiveness between intra-articular injection (IAI) of autologous platelet-rich plasma (PRP) vs hyaluronic acid (HA) vs activated PRP in primary osteoarthritis (OA) of the knee grades 1 and 2, in terms of pre- and postinjection functional outcome by the Western Ontario and McMaster Universities Arthritis Index (WOMAC) scale, and pre- and postinjection pain by visual analog scale (VAS). Materials and methods: The patients were divided into three groups based on the treatment they received. Group I received an HA injection of 25 mg, group II received an autologous PRP injection, and group III received an activated autologous PRP injection. The patients were evaluated primarily with WOMAC scale improvement and secondarily by VAS at the time of getting the injection (0), at the end of 1 month, and at the end of 3 months. Results: A total of 71 candidates were finally included in the study. Patients’ mean age of HA, PRP, and activated PRP was 54.5 ± 6.79, 55.47 ± 6.31, and 55.73 ± 7.33, respectively. In the HA group, the total WOMAC index decreased from 42.95 ± 3.49 to 21.29 ± 21.29, from 41.52 ± 4.17 to 18.91 ± 1.4 in the PRP group, and from 43.82 ± 4.67 to 18.91 ± 2.44 in the activated PRP group after 3 months (p-value is significant). Regarding the VAS scale, it significantly decreased after 3 months in the activated PRP group compared to others. Conclusion: The data revealed significant improvements in the WOMAC scale and VAS in all the groups at the 1- and 3-month follow-up visits. When comparing the change of WOMAC Scale and VAS at 1- and 3-month follow-ups, significant differences were found between the PRP and HA group and the activated PRP group, with activated PRP showing better outcomes compared to others.


PDF Share
  1. Kumar H, Pal CP, Sharma YK, et al. Epidemiology of knee osteoarthritis using Kellgren and Lawrence scale in Indian population. J Clin Orthop Trauma 2020;11(Suppl 1):S125–S129. DOI: 10.1016/j.jcot.2019.05.019
  2. Wearing SC, Hennig EM, Byrne NM, et al. Musculoskeletal disorders associated with obesity: a biomechanical perspective. Obes Rev 2006;7(3):239–250. DOI: 10.1111/j.1467-789X.2006.00251.x
  3. Pal S, Thuppal S, Reddy KJ, et al. Long-term (1-year) safety and efficacy of a single 6-mL injection of hylan G-F 20 in Indian patients with symptomatic knee osteoarthritis. Open Rheumatol J 2014;8:54–68. DOI: 10.2174/1874312901408010054
  4. Raeissadat SA, Karimzadeh A, Hashemi M, et al. Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial. BMC Musculoskelet Disord 2018;19(1):49. DOI: 10.1186/s12891-018-1963-4
  5. Raeissadat SA, Babaee M, Rayegani SM, et al. An overview of platelet products (PRP, PRGF, PRF, etc.) in the Iranian studies. Future Sci OA 2017;3(4):FSO231. DOI: 10.4155/fsoa-2017-0045
  6. Andia I, Sánchez M, Maffulli N. Joint pathology and platelet-rich plasma therapies. Expert Opin Biol Ther 2012;12(1):7–22. DOI: 10.1517/14712598.2012.632765
  7. Cole BJ, Seroyer ST, Filardo G, et al. Platelet-rich plasma: where are we now and where are we going? Sports Health 2010;2(3):203–210. DOI: 10.1177/1941738110366385
  8. Sakata R, McNary SM, Miyatake K, et al. Stimulation of the superficial zone protein and lubrication in the articular cartilage by human platelet-rich plasma. Am J Sports Med 2015;43(6):1467–1473. DOI: 10.1177/0363546515575023
  9. Wu CC, Chen WH, Zao B, et al. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials 2011;32(25):5847–5854. DOI: 10.1016/J.BIOMATERIALS.2011.05.002
  10. Montañez-Heredia E, Irízar S, Huertas PJ, et al. Intra-articular injections of platelet-rich plasma versus hyaluronic acid in the treatment of osteoarthritic knee pain: a randomized clinical trial in the context of the Spanish national health care system. Int J Mol Sci 2016;17(7): DOI: 10.3390/IJMS17071064
  11. Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013;41(2):356–364. DOI: 10.1177/0363546512471299
  12. Filardo G, Di Matteo B, Di Martino A, et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med 2015;43(7):1575–1582. DOI: 10.1177/0363546515582027
  13. Anitua E, Sánchez M, Aguirre JJ, et al. Efficacy and safety of plasma rich in growth factors intra-articular infiltrations in the treatment of knee osteoarthritis. Arthroscopy 2014;30(8):1006–1017. DOI: 10.1016/j.arthro.2014.05.021
  14. Raeissadat SA, Gharooee Ahangar A, Rayegani SM, et al. Platelet-rich plasma-derived growth factor vs hyaluronic acid injection in the individuals with knee osteoarthritis: a one year randomized clinical trial. J Pain Res 2020;13:1699–1711. DOI: 10.2147/JPR.S210715
  15. Elksniņš-Finogejevs A, Vidal L, Peredistijs A. Intra-articular platelet-rich plasma vs corticosteroids in the treatment of moderate knee osteoarthritis: a single-center prospective randomized controlled study with a 1-year follow up. J Orthop Surg Res 2020;15(1):257. DOI: 10.1186/S13018-020-01753-Z
  16. Görmeli G, Görmeli CA, Ataoglu B, et al. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc 2017;25(3):958–965. DOI: 10.1007/S00167-015-3705-6
  17. Singh D, Dinesh C, Manikandarajan A. Comparative study of clinical and functional outcome of treatment of mild to moderate osteoarthritis of knee joint between intra articular platelet rich plasma and Hyaluronic acid injection. Int J Orthop Sci 2020;6(4):202–208. DOI: 10.22271/ortho.2020.v6.i4d.2339
  18. Say F, Gürler D, Yener K, et al. Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis. Acta Chir Orthop Traumatol Cech 2013;80(4):278–283. PMID: 24119476.
  19. Cerza F, Carnì S, Carcangiu A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med 2012;40(12):2822–2827. DOI: 10.1177/0363546512461902
  20. Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 2011;27(11):1490–1501. DOI: 10.1016/J.ARTHRO.2011.05.011
  21. Cole BJ, Karas V, Hussey K, et al. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med 2017;45(2):339–346. DOI: 10.1177/0363546516665809
  22. Chinder PS, Samorekar B, Sridhar S, et al. Platelet-rich plasma as a boon for osteoarthritic knees - A prospective observational study. J Clin Diagnos Res 2018;12(3):RC06–RC09. DOI: 10.7860/JCDR/2018/31013.11244
  23. Ghai B, Gupta V, Jain A, et al. [Effectiveness of platelet rich plasma in pain management of osteoarthritis knee: double blind, randomized comparative study]. Braz J Anesthesiol 2019;69(5):439–447. DOI: 10.1016/J.BJAN.2019.06.003
  24. Chang KV, Hung CY, Aliwarga F, et al. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil 2014;95(3):562–575. DOI: 10.1016/J.APMR.2013.11.006
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.